Aishwin

AISHWIN is a prescription opioid analgesic containing Pentazocine Lactate. It acts primarily as a mixed agonist-antagonist at opioid receptors in the central nervous system, making it highly effective for managing moderate to severe acute pain. It is commonly utilized in clinical environments for preoperative sedation, as a supplement to surgical anesthesia, and for post-operative pain management. Because it carries a risk of dependence, tolerance, and respiratory depression, it is classified under strict regulatory schedules (noted by the NRx warning). AISHWIN must only be administered via subcutaneous, intramuscular, or intravenous routes by qualified healthcare professionals.